Menu
AbbVie announced that its contract pharmacy restrictions now apply to two new drugs: Elahere and Vyalev.

AbbVie Adds 340B Restrictions to Cancer, Parkinson’s Treatment Drugs

Shannon Young, Associate Editor/Senior Writer Views
A Chicago-based drugmaker recently added two new medications to its growing list of drugs subject to 340B contract pharmacy restrictions.  [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live